Fig. 2From: Finnish gelsolin amyloidosis causes significant disease burden but does not affect survival: FIN-GAR phase II studyNumber of skin surgeries in 89 patients with AGel amyloidosis in the FIN-GAR phase II registry, including eyelid and other facial surgeries, hernia and prolapse surgeries, and varicose vein surgeriesBack to article page